Data Bridge Market Research analyses that the primary immunodeficiency market which was USD 7.8 billion in 2022, would rocket up to USD 12.9 billion by 2030, and is expected to undergo a CAGR of 6.5% during the forecast period.
menu
- home Home
- newspaper News
- feed Guest Post
- attach_money Price
- contact_support Contact
- monetization_on Donate/Support
-
English- English (en)
- Arabic (ar)
- Chinese Simplified (zh_CN)
- French (fr)
- German (de)
- Hindi (hi)
- Irish (ga)
- Italian (it)
- Japanese (ja)
- Korean (ko)
- Russian (ru)
- Spanish (es)
- Turkish (tr)
- Urdu (ur)
- Bengali (bn)
- Afrikaans (af)
- Greek (el)
- Indonesian (id)
- Georgian (ka)
- Dutch (nl)
- Portuguese (Brazil) (pt_BR)
- Vietnamese (vi)
- Ukrainian (uk)
- Filipino (tl)
Copyright © 2025 Times Square Reporter. All rights reserved.
Comments
0 comment